• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

宿主-环境医学:基因组学时代的初级保健模式。

Host-environment medicine: a primary care model for the age of genomics.

作者信息

Rabinowitz Peter M, Poljak Alex

机构信息

Department of Internal Medicine, Yale University School of Medicine, New Haven, Conn 06510, USA.

出版信息

J Gen Intern Med. 2003 Mar;18(3):222-7. doi: 10.1046/j.1525-1497.2003.11101.x.

DOI:10.1046/j.1525-1497.2003.11101.x
PMID:12648255
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC1494830/
Abstract

Rapid developments in genomic and proteomic testing promise to impact the way in which clinicians assess disease risk and drug selection in their patients. Because most diseases result from host-environment interactions, however, primary care providers will need to avoid the trap of biological determinism by examining the important role of environmental factors in their clinical assessments and interventions. This article discusses the application of host-environment concepts to recent developments in the areas of genomics and proteomics.

摘要

基因组学和蛋白质组学检测的快速发展有望影响临床医生评估患者疾病风险和选择药物的方式。然而,由于大多数疾病是由宿主与环境的相互作用引起的,初级保健提供者需要通过审视环境因素在其临床评估和干预中的重要作用,避免陷入生物决定论的陷阱。本文讨论了宿主 - 环境概念在基因组学和蛋白质组学领域最新发展中的应用。

相似文献

1
Host-environment medicine: a primary care model for the age of genomics.宿主-环境医学:基因组学时代的初级保健模式。
J Gen Intern Med. 2003 Mar;18(3):222-7. doi: 10.1046/j.1525-1497.2003.11101.x.
2
Clinical application of pharmacogenetics in pain management.临床药理学在疼痛管理中的应用。
Per Med. 2018 Mar;15(2):117-126. doi: 10.2217/pme-2017-0032. Epub 2018 Jan 31.
3
The cytochrome P450 2D6 (CYP2D6) enzyme polymorphism: screening costs and influence on clinical outcomes in psychiatry.细胞色素P450 2D6(CYP2D6)酶多态性:筛查成本及其对精神病学临床结局的影响
Clin Pharmacol Ther. 1996 Nov;60(5):522-34. doi: 10.1016/S0009-9236(96)90148-4.
4
[Effect of therapeutic drug monitoring of amitriptyline and genotyping on efficacy and safety of depression therapy].[阿米替林治疗药物监测及基因分型对抑郁症治疗疗效和安全性的影响]
Psychiatr Pol. 2000 Jul-Aug;34(4):595-605.
5
Ultrarapid metabolism of clomipramine in a therapy-resistant depressive patient, as confirmed by CYP2 D6 genotyping.通过CYP2 D6基因分型证实,一名难治性抑郁症患者存在氯米帕明超快速代谢现象。
Pharmacopsychiatry. 1998 Mar;31(2):72. doi: 10.1055/s-2007-979303.
6
The AmpliChip CYP450 genotyping test: Integrating a new clinical tool.AmpliChip CYP450基因分型检测:整合一种新的临床工具。
Mol Diagn Ther. 2006;10(3):135-51. doi: 10.1007/BF03256453.
7
Genomics and proteomics: how long do we need to reach clinical results?基因组学和蛋白质组学:我们需要多长时间才能获得临床结果?
Blood Purif. 2013;36(1):7-11. doi: 10.1159/000350578. Epub 2013 May 25.
8
Clomipramine, fluoxetine and CYP2D6 metabolic capacity in depressed patients.氯米帕明、氟西汀与抑郁症患者的CYP2D6代谢能力
Hum Psychopharmacol. 2004 Jul;19(5):293-8. doi: 10.1002/hup.598.
9
Citalopram: an interaction study with clomipramine in a patient heterozygous for CYP2D6 genotype.西酞普兰:对一名细胞色素P450 2D6基因杂合型患者进行的与氯米帕明的相互作用研究。
Pharmacopsychiatry. 1999 Nov;32(6):232-4. doi: 10.1055/s-1999-7960.
10
A case report of a poor metabolizer of CYP2D6 presented with unusual responses to nortriptyline medication.一例CYP2D6代谢不良者对去甲替林药物出现异常反应的病例报告。
J Korean Med Sci. 2004 Oct;19(5):750-2. doi: 10.3346/jkms.2004.19.5.750.

引用本文的文献

1
Exposomics: a review of methodologies, applications, and future directions in molecular medicine.暴露组学:分子医学中的方法、应用及未来方向综述
EMBO Mol Med. 2025 Apr;17(4):599-608. doi: 10.1038/s44321-025-00191-w. Epub 2025 Jan 27.
2
The ethical aspects of exposome research: a systematic review.暴露组研究的伦理问题:一项系统综述。
Exposome. 2023 Apr 12;3(1):osad004. doi: 10.1093/exposome/osad004.
3
From "us vs. them" to "shared risk": can animals help link environmental factors to human health?从“我们与他们”到“共同风险”:动物能帮助将环境因素与人类健康联系起来吗?
Ecohealth. 2008 Jun;5(2):224-9. doi: 10.1007/s10393-008-0170-4. Epub 2008 May 7.
4
Responding to the challenge of clinically relevant osteopathic research: efficacy and beyond.应对临床相关整骨疗法研究的挑战:疗效及其他。
Int J Osteopath Med. 2007 Mar;10(1):3. doi: 10.1016/j.ijosm.2007.01.002.
5
Systems biology: new approaches to old environmental health problems.系统生物学:解决旧有环境卫生问题的新方法。
Int J Environ Res Public Health. 2005 Apr;2(1):4-9. doi: 10.3390/ijerph2005010004.

本文引用的文献

1
Patient-tailored antiemetic treatment with 5-hydroxytryptamine type 3 receptor antagonists according to cytochrome P-450 2D6 genotypes.根据细胞色素P-450 2D6基因型使用5-羟色胺3型受体拮抗剂进行个体化止吐治疗。
J Clin Oncol. 2002 Jun 15;20(12):2805-11. doi: 10.1200/JCO.2002.09.064.
2
Polymorphism of the N-acetyltransferase 2 gene as a susceptibility risk factor for antituberculosis drug-induced hepatitis.N-乙酰转移酶2基因多态性作为抗结核药物性肝炎的易感性危险因素。
Hepatology. 2002 Apr;35(4):883-9. doi: 10.1053/jhep.2002.32102.
3
Use of proteomic patterns in serum to identify ovarian cancer.利用血清中的蛋白质组模式来识别卵巢癌。
Lancet. 2002 Feb 16;359(9306):572-7. doi: 10.1016/S0140-6736(02)07746-2.
4
Peroxisome proliferator--activated receptor alpha gene regulates left ventricular growth in response to exercise and hypertension.过氧化物酶体增殖物激活受体α基因可调节左心室在运动和高血压刺激下的生长。
Circulation. 2002 Feb 26;105(8):950-5. doi: 10.1161/hc0802.104535.
5
Pharmacogenetics and pharmacoepidemiology.药物遗传学与药物流行病学。
Pharmacoepidemiol Drug Saf. 2001 Aug-Sep;10(5):457-61. doi: 10.1002/pds.599.
6
Polyunsaturated fatty acids modulate the effects of the APOA1 G-A polymorphism on HDL-cholesterol concentrations in a sex-specific manner: the Framingham Study.多不饱和脂肪酸以性别特异性方式调节APOA1基因G-A多态性对高密度脂蛋白胆固醇浓度的影响:弗雷明汉心脏研究
Am J Clin Nutr. 2002 Jan;75(1):38-46. doi: 10.1093/ajcn/75.1.38.
7
Pharmacogenetic screening and therapeutic drugs.
Clin Chim Acta. 2002 Jan;315(1-2):137-55. doi: 10.1016/s0009-8981(01)00713-6.
8
Clinical proteomics: personalized molecular medicine.临床蛋白质组学:个性化分子医学。
JAMA. 2001 Nov 14;286(18):2211-4. doi: 10.1001/jama.286.18.2211.
9
Association of a single nucleotide polymorphism in the TIGR/MYOCILIN gene promoter with the severity of primary open-angle glaucoma.TIGR/MYOCILIN基因启动子单核苷酸多态性与原发性开角型青光眼严重程度的关联
Clin Genet. 2001 Sep;60(3):220-5. doi: 10.1034/j.1399-0004.2001.600308.x.
10
Ethnic and genetic differences in metabolism genes and risk of toxicity and cancer.代谢基因中的种族和遗传差异以及毒性和癌症风险。
Sci Total Environ. 2001 Jul 2;274(1-3):93-102. doi: 10.1016/s0048-9697(01)00732-x.